207 related articles for article (PubMed ID: 15124136)
1. Treatment of chronic lymphocytic leukemia.
Ferrajoli A; O'Brien SM
Semin Oncol; 2004 Apr; 31(2 Suppl 4):60-5. PubMed ID: 15124136
[TBL] [Abstract][Full Text] [Related]
2. [First-line therapy of chronic lymphocytic leukemia in the elderly: be careful with overtreatment].
Bauduer F
Presse Med; 2009 Jan; 38(1):140-2. PubMed ID: 19004611
[No Abstract] [Full Text] [Related]
3. Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies.
Robak T
Transfus Apher Sci; 2005 Feb; 32(1):33-44. PubMed ID: 15737872
[TBL] [Abstract][Full Text] [Related]
4. Bendamustine in the treatment of chronic lymphocytic leukemia: results and future perspectives.
Aivado M; Schulte K; Henze L; Burger J; Finke J; Haas R
Semin Oncol; 2002 Aug; 29(4 Suppl 13):19-22. PubMed ID: 12170428
[TBL] [Abstract][Full Text] [Related]
5. Chemoimmunotherapy of chronic lymphocytic leukemia.
Tam CS; Keating MJ
Nat Rev Clin Oncol; 2010 Sep; 7(9):521-32. PubMed ID: 20603650
[TBL] [Abstract][Full Text] [Related]
6. What choices are available for treatment of the patient with chronic lymphocytic leukemia who is fludarabine-refractory?
Byrd JC; Rai KR
Semin Oncol; 2000 Aug; 27(4):xii-xv; discussion xv-xvi. PubMed ID: 10950363
[No Abstract] [Full Text] [Related]
7. Treatment options for newly diagnosed patients with chronic lymphocytic leukemia.
Erba HP
Curr Hematol Rep; 2004 Jan; 3(1):47-53. PubMed ID: 14695850
[TBL] [Abstract][Full Text] [Related]
8. Fludarabine in chronic lymphocytic leukaemia.
Elter T; Hallek M; Engert A
Expert Opin Pharmacother; 2006 Aug; 7(12):1641-51. PubMed ID: 16872267
[TBL] [Abstract][Full Text] [Related]
9. Chemoimmunotherapy of chronic lymphocytic leukemia.
Tam CS; Keating MJ
Best Pract Res Clin Haematol; 2007 Sep; 20(3):479-98. PubMed ID: 17707835
[TBL] [Abstract][Full Text] [Related]
10. [Evidence-based therapy for chronic leukemia].
Okamoto S
Nihon Naika Gakkai Zasshi; 2003 Jun; 92(6):979-85. PubMed ID: 12866442
[No Abstract] [Full Text] [Related]
11. [Current concepts in chronic lymphocytic leukemia. Better chances for young patients].
Hallek M; Bergmann M; Goede V; Fingerle-Rowson G; Schweighofer C; Schmitt B; Wendtner CM; Emmerich B
MMW Fortschr Med; 2003 Jul; 145(27-28):46-9. PubMed ID: 14587189
[No Abstract] [Full Text] [Related]
12. Charting the path to the cure of chronic lymphocytic leukemia: consolidation strategies currently lead the way.
Tam CS
Leuk Lymphoma; 2009 Oct; 50(10):1557-8. PubMed ID: 19757304
[No Abstract] [Full Text] [Related]
13. Chronic lymphocytic leukaemia. Current strategy and new perspectives of treatment.
Rai KR
Haematologica; 1999 Jun; 84 Suppl EHA-4():94-5. PubMed ID: 10907481
[No Abstract] [Full Text] [Related]
14. Pilot experience with continuous infusion alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia.
Ferrajoli A; Wierda WG; LaPushin R; O'Brien SM; Faderl S; Browning ML; Keating MJ
Eur J Haematol; 2008 Apr; 80(4):296-8. PubMed ID: 18182081
[TBL] [Abstract][Full Text] [Related]
15. Evolving role of monoclonal antibodies in the treatment of chronic lymphocytic leukemia.
Kharfan-Dabaja MA; Fahed R; Hussein M; Santos ES
Expert Opin Investig Drugs; 2007 Nov; 16(11):1799-815. PubMed ID: 17970639
[TBL] [Abstract][Full Text] [Related]
16. Post-remission intervention with alemtuzumab or rituximab to eradicate minimal residual disease in chronic lymphocytic leukemia: where do we stand?
Van Den Neste E; Letestu R; Aurran-Schleinitz T; Ysebaert L; Feugier P; Leprêtre S; Dartigeas C
Leuk Lymphoma; 2012 Mar; 53(3):362-70. PubMed ID: 21854093
[TBL] [Abstract][Full Text] [Related]
17. Fludarabine plus rituximab for untreated B-cell chronic lymphocytic leukemia.
Castagna L; Sarina B; Santoro A
Blood; 2003 Sep; 102(6):2309; author reply 2309-10. PubMed ID: 12959942
[No Abstract] [Full Text] [Related]
18. Chemotherapy: New FluCam combination therapy has familiar limitations.
Woyach JA; Byrd JC
Nat Rev Clin Oncol; 2011 Dec; 9(1):14-5. PubMed ID: 22143135
[No Abstract] [Full Text] [Related]
19. Ofatumumab is active in patients with fludarabine-refractory CLL irrespective of prior rituximab: results from the phase 2 international study.
Wierda WG; Padmanabhan S; Chan GW; Gupta IV; Lisby S; Osterborg A;
Blood; 2011 Nov; 118(19):5126-9. PubMed ID: 21856867
[TBL] [Abstract][Full Text] [Related]
20. Alemtuzumab in chronic lymphocytic leukemia.
James DF; Kipps TJ
Future Oncol; 2007 Feb; 3(1):29-42. PubMed ID: 17280499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
